SLC25A12 and pancreatic neoplasm: The role of AGC1 as cytosolic aspartate supplier was further investigated by Furkan Alkan which demonstrated that AGC1 knockdown slows in vivo growth of mouse lung and pancreas cancer cells, reduces cellular NAD+/NADH ratio, and impairs aspartate supply to cytosol.